Details of the Drug

General Information of Drug (ID: DMYD8GP)

Drug Name
5-Ethyl-3-methyl-5-phenyl-oxazolidine-2,4-dione
Synonyms CHEMBL41666; 5-Ethyl-3-methyl-5-phenyl-oxazolidine-2,4-dione; BDBM50227231; 68475-20-7
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 219.24
Logarithm of the Partition Coefficient (xlogp) 2.1
Rotatable Bond Count (rotbonds) 2
Hydrogen Bond Donor Count (hbonddonor) 0
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C12H13NO3
IUPAC Name
5-ethyl-3-methyl-5-phenyl-1,3-oxazolidine-2,4-dione
Canonical SMILES
CCC1(C(=O)N(C(=O)O1)C)C2=CC=CC=C2
InChI
InChI=1S/C12H13NO3/c1-3-12(9-7-5-4-6-8-9)10(14)13(2)11(15)16-12/h4-8H,3H2,1-2H3
InChIKey
BWNMMRKYEBCJHN-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
12488718
TTD ID
D0L5UC

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Sodium channel unspecific (NaC) TTRK8B9 NOUNIPROTAC Inhibitor [1]
Voltage-gated sodium channel alpha Nav1.3 (SCN3A) TTAXZ0K SCN3A_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Sodium channel binding and anticonvulsant activities for the enantiomers of a bicyclic 2,4-oxazolidinedione and monocyclic models. J Med Chem. 1989 Jul;32(7):1577-80.